model updat rais pt
updat sales/ep estim
organ revenu recog adj
exhibit sale decreas mostli neg
revenu recognit impact cc organ sell day
adjust growth actual forecast gm/om/tax
consensu manag organ
growth guidanc ep rang rais
pt prior remain buy rate
valuat risk like syk reliabl strong sale growth
diversif well upsid potenti via futur accret
seemingli genuin focu margin improv period
revenu forecast show compound-annual-growth-rate unreason
presum anoth point inorgan growth use rel valuat
framework regress forward sale compound-annual-growth-rate vs rel forward peer
price-to-earnings ascrib rel forward price-to-earnings premium convolv
month averag forward multipl anticip
ep month henc arriv revis price target risk
target price includ inabl mako drive share gain hospit
capital-expenditure declin failur deliv promis margin expans and/or maintain
due acquisit misstep and/or downward reset recent
tr target
exhibit revenu varianc segment product categori
page
strh estimatesstrhconsensusno ofstrh vs consensu cc pt handl emerg spineneurotechnolog neurotechnolog total stryker corpor
page
page
therapytot incom inc med-tech w/ analysisgross analysissal cc sd cc extrem orthoped total neurotech spine ep stryker corpor
global compani provid medic technolog product servic busi
segment orthoped medsurg neurotechnolog spine compani found
homer stryker incorpor headquart kalamazoo mi
believ strength brand us compani proven abil maxim
impact acquir technolog busi upon incorpor syk excel commerci
organ support target price
valuat risk
like syk reliabl strong sale growth diversif well upsid potenti via futur
accret seemingli genuin focu margin improv period
revenu forecast show compound-annual-growth-rate unreason presum anoth point inorgan
growth use rel valuat framework regress forward sale compound-annual-growth-rate vs rel
forward peer price-to-earnings ascrib rel forward price-to-earnings premium convolv
month averag forward multipl anticip ep month henc
arriv revis price target risk target price includ inabl mako
drive share gain hospit capital-expenditure declin failur deliv promis margin expans and/or
maintain due acquisit misstep and/or downward reset recent market multipl
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
